Requisite Capital Management, LLC Cassava Sciences Inc Transaction History

Requisite Capital Management, LLC

  • $456 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$32.6 - $53.05 $652,000 - $1.06 Million
-20,000 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$36.77 - $90.91 $735,400 - $1.82 Million
20,000 New
20,000 $874,000

Others Institutions Holding SAVA

# of Institutions
187
Shares Held
13.5M
Call Options Held
1.42M
Put Options Held
2.05M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.05B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Requisite Capital Management, LLC Portfolio

Follow Requisite Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Requisite Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email